SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BrokeCoin is a meme-meets-utility cryptocurrency project operating under the ethos of Transparency, Community, and Respect. Formally registered as an LLC in Wyoming, USA, BrokeCoin is building an expansive ecosystem that combines light-hearted spirit of meme culture with real-world crypto utilities—spanning gaming, staking, NFTs, web services, and an e-commerce platform. Brokecoin believes in developing useful and interesting meme-inspired utilities to both service the crypto industry, and generate value for holders.

Brokecoin

Brokecoin is trending as the community rallies around upcoming developments like staking and burns, celebrating its accessibility via CEX listing. The community is also actively working toward a watcher milestone that will trigger another token burn. $BROKE.X is up significantly this week as the community's grind and long-term vision gain more attention.

Infinite Money Glitch ($IMG) is revolutionizing DeFi on Solana by leveraging the Token2022 program's advanced tax extension capabilities to create a truly innovative reward system for token holders.  At its core, $IMG implements a seamless 5% tax on all transactions - whether buying, selling, or transferring tokens. This tax is automatically collected and distributed to holders in SOL, creating a sustainable passive income stream for the community. 4.5% of the tax gets sent to holders, while .5% gets sent to an Infrastructure wallet to help with development, marketing and general infrastructure.  What sets $IMG apart is its implementation of Solana's Token2022 program, enabling automated and efficient reward distribution without relying on external smart contracts.

Infinite Money Glitch

IMG.X, or Infinite Money Glitch, is trending as community members highlight its unique rewards system, which pays holders in $SOL.X just for holding. Many are drawn to the concept of steady Solana rewards and the potential for high APY based on trading volume, viewing it as a community-owned protocol that challenges traditional finance models. Discussions also revolve around the project's resilience and recent partnerships, generating excitement for its future within the Solana ecosystem.

Dog (Bitcoin) is a fully decentralized memecoin on the Bitcoin blockchain, backed by a community dedicated to onboarding millions of people to Bitcoin.  Dog is secured by the Bitcoin blockchain and exists on Bitcoin L1, marking a significant innovation compared to Bitcoin with just BTC. Dog is a Bitcoin Runes token with a minimal on-chain footprint, native to Bitcoin, and stored in UTXOs, just like Bitcoin.   What is the project about?  Dog does not do any paid promotion and is fully decentralized just like Bitcoin. Every influencer who chooses to post about Dog either received the airdrop or bought on secondary. Dog leverages the CC0 license to ensure that Dog is not owned by any single entity but rather by everyone. This had lead to the "DOG Army" independently creating art, apps, lotteries, plushies, websites, podcast, magazines, X account, IRL meetups, clothing lines, PFP collections, Telegram groups, and TikTok/Instagram about Dog.  What makes your project unique?  Dog was airdropped in the fairest memecoin launch ever. In early 2024, the Bitcoin Ordinals ecosystem came together in a full volunteer initiative that rewarded early adopters of the Ordinals Protocol. There was no team allocation, and 100% of the supply was airdropped for free. The airdrop algorithm favored neither whales nor influencers; it was determined by the community and made open-source for maximum transparency.

Dog (Bitcoin)

Dog (Bitcoin) is trending as community members highlight its strong engagement across platforms and its position as the first Bitcoin-native meme asset. Bullish sentiment is fueled by its connection to Bitcoin, fair launch, and potential listings on major exchanges. Some traders are pointing to recent news about a publicly listed company increasing their holdings in $DOG.X.

This platform is engineered to unlock the full potential of Real-World Assets (RWAs) by bringing them onto the XRP Ledger with unparalleled efficiency. Our purpose is to democratize access to high-value assets by providing a streamlined, end-to-end solution for tokenization. Functionally, we offer tools for asset verification, compliant legal wrapping, and the minting of RWA tokens. The project's core utility is twofold: for asset owners, it unlocks immediate liquidity and access to global capital markets; for investors, it offers fractional, transparent, and liquid access to investment classes like private equity and infrastructure bonds. We leverage the XRPL's native speed and built-in DEX to ensure low-cost transactions and instant settlement, setting a new standard for RWA interoperability and finance.

VOLT

VOLT ($XVM.X) is trending as the community discusses its potential as a real-world asset (RWA) token, with some comparing it to established cryptocurrencies like XRP and XLM.  Enthusiasm is fueled by its relatively low market cap, leading to speculation about significant growth potential and comparisons to other RWA projects. Some users are inquiring about where to purchase the token and sharing their initial investments.

Gyrodyne LLC engages in the management of a portfolio of medical office and industrial properties. Its properties include Flowerfield, Port Jefferson Professional Park, Courtland Medical Center, and Grove. The company was founded by Peter James Papadakos in 1946 and is headquartered in St. James, NY.

Gyrodyne LLC

GYRO is trending due to news of a land sale boosting NAV, with the community noting its small float and potential for a significant upward move. Discussions revolve around it being undervalued, with some comparing it to other low-float runners and anticipating a potential squeeze. The stock's low float and recent positive news are attracting attention, with traders eyeing key breakout levels.

Forward Industries, Inc. engages in the provision of integrated design, development, and manufacturing solutions for top tier medical and technology customers worldwide. It operates through the following segments: OEM Distribution, Retail Distribution, and Design. The OEM Distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices. The Retail Distribution segment sells smart-enabled furniture and a variety of other products through agreements with various retailers, both in stores and through online retailer websites. The Design segment provides hardware and software product design and engineering services. The company was founded in 1961 and is headquartered in Hauppauge, NY.

Forward Industries, Inc.

Forward Industries ($FORD) is trending due to a significant after-hours price surge, leaving some traders initially mistaking it for Ford Motor Company ($F). The stock is being discussed as a low float play with potential for further gains, with some drawing comparisons to other recent runners. Community members are debating whether the surge is sustainable or a short-term pump.

Southport Acquisition Corp. is a blank check company, which engages for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was founded on April 13, 2021 and is headquartered in Fairfield, CT.

Southport Acquisition Corp - Ordinary Shares - Class A

Southport Acquisition Corp (PORT) is trending due to its upcoming merger with Angel Studios, expected to be completed around September 11th, with investors discussing the potential for significant gains. The community is focused on the conversion ratios of common shares, warrants ($PORTW), and Angel shares into the new $ANGX ticker, as well as the potential valuation post-merger. There is also interest in Angel Studios' growth, particularly the increase in Guild subscribers and revenue.

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

CRISPR Therapeutics AG

CRISPR Therapeutics is trending as investors discuss the potential impact of upcoming presentations and data releases. The community is focused on analyst target prices and potential market manipulation, with some speculating on a possible deal between institutional investors and ARKK. Bullish sentiment remains strong due to the long-term potential of gene editing and the anticipation of positive news.

Innodata, Inc. is a data engineering company, which engages in providing artificial intelligence software platforms and management of its services. It operates through the following business segments: Digital Data Solutions (DDS), Synodex, and Agility. The DDS segment combines deep neural networks and human expertise in multiple domains to make unstructured information useable. The Synodex segment enables clients in the insurance and healthcare sectors to transform medical records into useable digital data and to apply technologies to the digital data to augment decision support. The Agility segment provides tools and related professional services that enable public relations and communications professionals to discover influencers, amplify messages, monitor coverage, and measure the impact of campaigns. The company was founded by Todd H. Solomon in 1988 and is headquartered in Ridgefield Park, NJ.

Innodata Inc

Innodata is trending amid community debate over its valuation and future catalysts, particularly following recent earnings and raised guidance. Discussions revolve around technical analysis versus fundamental strength, with some highlighting potential for a market correction. Community members are closely watching for news of contract wins or a possible acquisition.

Atara Biotherapeutics, Inc. is an allogeneic T-cell immunotherapy company, which engages in the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers, and autoimmune diseases. It also delivers off-the-shelf treatments to patients with high unmet medical need. Its product pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in Thousand Oaks, CA.

Atara Biotherapeutics Inc

Atara Biotherapeutics is trending following news of FDA priority review for its therapy Tab-cel, with a decision expected in early 2026. Community members are actively discussing the potential impact of this regulatory milestone and comparing it to past CRL situations, while also noting recent insider buying activity. Some traders are pointing to the company's financial position and pipeline developments, speculating on future strategic options and potential for growth.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Fast-paced Momentum Stock Beauty Health (SKIN) Is Still Trading at a Bargain

Beauty Health (SKIN) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.

International Markets and Beauty Health (SKIN): A Deep Dive for Investors

Examine the evolution of Beauty Health's (SKIN) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.

Beauty Health (SKIN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates

The headline numbers for Beauty Health (SKIN) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

The Beauty Health Company (SKIN) Surpasses Q2 Earnings and Revenue Estimates

Beauty Health (SKIN) delivered earnings and revenue surprises of +150.00% and +4.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Cencora (COR) Q3 Earnings and Revenues Surpass Estimates

Cencora (COR) delivered earnings and revenue surprises of +5.82% and +0.41%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

The Beauty Health Company (SKIN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Beauty Health (SKIN) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Revvity (RVTY) Surpasses Q2 Earnings and Revenue Estimates

Revvity (RVTY) delivered earnings and revenue surprises of +3.51% and +1.27%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Why Fast-paced Mover Beauty Health (SKIN) Is a Great Choice for Value Investors

If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Beauty Health (SKIN) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.

Despite Fast-paced Momentum, Beauty Health (SKIN) Is Still a Bargain Stock

Beauty Health (SKIN) Reliance on International Sales: What Investors Need to Know

The Beauty Health Co. engages in the design, development, manufacture, marketing, and sale of esthetic technologies and products. Its brands include Hydrafacial, SkinStylus, and Keravive. The company was founded in 1997 and is headquartered in Long Beach, CA.

SKIN
Beauty Health Company (The) - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest SKIN News

SKIN Beauty Health Company (The) - Ordinary Shares - Class A